168 related articles for article (PubMed ID: 3954277)
1. Risks for renal dysfunction with cardiac angiography.
Taliercio CP; Vlietstra RE; Fisher LD; Burnett JC
Ann Intern Med; 1986 Apr; 104(4):501-4. PubMed ID: 3954277
[TBL] [Abstract][Full Text] [Related]
2. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
Manske CL; Sprafka JM; Strony JT; Wang Y
Am J Med; 1990 Nov; 89(5):615-20. PubMed ID: 2239981
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
[TBL] [Abstract][Full Text] [Related]
4. Radiocontrast nephropathy: is it dose related or not?
Mekan SF; Rabbani MA; Azhar-uddin M; Ali SS
J Pak Med Assoc; 2004 Jul; 54(7):372-4. PubMed ID: 15449920
[TBL] [Abstract][Full Text] [Related]
5. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest.
Petek BJ; Bravo PE; Kim F; de Boer IH; Kudenchuk PJ; Shuman WP; Gunn ML; Carlbom DJ; Gill EA; Maynard C; Branch KR
Ann Emerg Med; 2016 Apr; 67(4):469-476.e1. PubMed ID: 26363571
[TBL] [Abstract][Full Text] [Related]
7. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.
Cigarroa RG; Lange RA; Williams RH; Hillis LD
Am J Med; 1989 Jun; 86(6 Pt 1):649-52. PubMed ID: 2729314
[TBL] [Abstract][Full Text] [Related]
8. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
9. Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.
Tadros GM; Mouhayar EN; Akinwande AO; Campbell B; Wood C; Blankenship JA
J Invasive Cardiol; 2003 Jun; 15(6):311-4. PubMed ID: 12777667
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.
Frank H; Werner D; Lorusso V; Klinghammer L; Daniel WG; Kunzendorf U; Ludwig J
Clin Nephrol; 2003 Sep; 60(3):176-82. PubMed ID: 14524580
[TBL] [Abstract][Full Text] [Related]
11. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media.
Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG
AJR Am J Roentgenol; 1991 Jul; 157(1):59-65. PubMed ID: 2048540
[TBL] [Abstract][Full Text] [Related]
12. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance.
Albert SG; Shapiro MJ; Brown WW; Goodgold H; Zuckerman D; Durham R; Kern M; Fletcher J; Wolverson M; Plummer ES
Invest Radiol; 1994 Jun; 29(6):618-23. PubMed ID: 8088970
[TBL] [Abstract][Full Text] [Related]
13. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
14. Radiocontrast-associated renal dysfunction: incidence and risk factors.
Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG; Sprayregen S
AJR Am J Roentgenol; 1991 Jul; 157(1):49-58. PubMed ID: 2048539
[TBL] [Abstract][Full Text] [Related]
15. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery.
Ranucci M; Ballotta A; Kunkl A; De Benedetti D; Kandil H; Conti D; Mollichelli N; Bossone E; Mehta RH
Am J Cardiol; 2008 Apr; 101(8):1112-8. PubMed ID: 18394443
[TBL] [Abstract][Full Text] [Related]
16. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
18. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
[TBL] [Abstract][Full Text] [Related]
19. Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography.
Chaykovska L; Heunisch F; von Einem G; Alter ML; Hocher CF; Tsuprykov O; Dschietzig T; Kretschmer A; Hocher B
PLoS One; 2016; 11(1):e0145723. PubMed ID: 26751954
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
